QUMAS, a leading provider of quality management and regulatory affairs solutions, today announced that Sean Winslow, global implementation consulting manager for QUMAS, will speak on "Risk-Based Software Validation Techniques" at the Drug Information Society (DIA) 43rd Annual Meeting on June 19, from 4 to 5:30 p.m., at the Georgia World Congress Center in Atlanta, Georgia.

In his presentation, Winslow will discuss some of the latest approaches to validating software. Specifically, he will review how risk-based research and establishing validation standards can be maximized for better business benefit.

Winslow has more than 10 years of IT project management experience with expertise in compliance systems implementation, data storage and system consolidation and computerized systems validation. He has held senior project management positions with Andrx Pharmaceuticals, Millennium Pharmaceuticals, Biogen Idec, Boehringer Ingelheim and GlaxoSmithKline. Winslow has a bachelor's degree in business management from Rutgers University.

Additionally, QUMAS is an exhibitor at booth #651 June 17-20. QUMAS representatives will be in attendance to discuss and demo the QUMAS Compliance Suite™, a complete compliance software solution that enables life sciences companies to standardize the common element of compliance activities across the organization and provides a risk-based approach to compliance decision-making. With the QUMAS Compliance Suite organizations can eliminate the cost of managing disparate and isolated applications; avoid duplication and ongoing validation costs; and optimize performance levels to accelerate the delivery of new products.

About QUMAS
QUMAS is a leading developer of enterprise compliance management solutions designed to help life sciences organizations meet industry and government standards for 21 CFR Part 11, cGxP, Quality, Regulatory Affairs and Clinical Operations. With over a decade of experience, QUMAS is helping companies accelerate business processes, reduce costs and improve quality. From content lifecycle management, business process and change management to reporting and analysis, QUMAS Compliance Suite is successfully enabling global life science organizations to proactively manage their regulated content and processes in a secure and compliant way.

For more information visit http://www.qumas.com.